Health Care
McKesson (MCK) delivered a strong fiscal year 2026, with revenue surging 12.4% to $403.4B and net income jumping 44.5% to $4.76B, driven by operating leverage and aggressive share buybacks that boosted EPS by 49.1% to $38.55.
Key risk: Negative Stockholders' Equity
MCK carries a stockholders' equity deficit of -$2.17B, which deepened from -$2.07B in the prior year. This structural negative equity, driven by cumulative share buybacks exceeding retained earnings, could limit financial flexibility and raise concerns among lenders or counterparties.
Other Health Care Distributors companies